We studied the control of forearm vascular resistance (FVR) by cardiopulmonary receptors in seven patients with hypertension and left ventricular hypertrophy (LVH) and in seven normotensive control subjects. Increasing levels of lower body negative pressure (LBNP) (-10 and -40 mm Hg) induced a progressive decrease in central venous pressure (CVP) and an increase in FVR. The changes in these two variables were correlated both in normal subjects and patients with hypertension (slope for normal subjects = -29.9, for patients with hypertension = -40.3, NS). After propranolol, there was a significant reduction in the increase in FVR induced by -40 mm Hg LBNP in normal subjects (+ 107 ± 5 vs + 129 ± 15 mm Hg/ml/sec, p < .05) but not in patients with hypertension. Consequently, the slope of the ACVP/AFVR regression was reduced in normal subjects ( -20.6, p < .01) but not in patients with hypertension. In another seven normal subjects and seven patients with hypertension and LVH we assessed the effects of -10 and -40 mm Hg LBNP on left ventricular filling pressure (LVFP). LBNP induced similar changes in CVP, LVFP, and total peripheral resistance both in normal subjects and in patients with hypertension. Propranolol failed to modify the effects of LBNP on CVP and LVFP in both groups and reduced the response of total peripheral resistance to -40 mm Hg LBNP only in normal subjects. Propranolol did not reduce the response of FVR to the cold pressor test and sustained handgrip or the arterial baroreflex response to the injection of phenylephrine and increased neck tissue pressure. Thus, hypertension-induced LVH seems to be associated with a selective impairment of the left ventricular sensory receptors. Circulation 74, No. 5, 980-990, 1986. ALTHOUGH it has been demonstrated that cardiopulmonary baroreceptors play an important role in the reflex control of systemic circulation1 2 and that these receptors may be impaired in patients with left ventricular dysfunction due to ischemic, viral, or idiopathic cardiomyopathy,3 few data are available on the effects of hypertension-induced left ventricular hypertrophy (LVH) on cardiopulmonary receptor function. In dogs with renovascular hypertension4 and in spontaneously hypertensive rats with cardiac hypertrophy,5 a resetting of cardiopulmonary as well as arterial baroreceptors has been reported. In humans, an enhancement of the tonic influence of cardiopulmonary baroreceptors has been described in patients with borderline hyper-CIRCULATION 980
tension. 6 In contrast, patients with severe hypertension and cardiac hypertrophy do not exhibit this exaggerated reflex response to orthostatic stress. 7 Recently, Ferguson et al. 8 have demonstrated that left ventricular sensory receptors play an important role in reflex adjustments to orthostatic stress in humans. In particular, these authors have shown that propranolol, which has been reported to selectively reduce the firing of ventricular receptors with nonmedullated vagal afferents,9 is able to attenuate the peripheral vasoconstrictor response induced by lower body negative pressure (LBNP).
The present study was undertaken to define the effects of LVH on cardiopulmonary baroreceptor function in human hypertension by evaluating the hemodynamic response to graded LBNP. Low levels of LBNP induce a decrease in central venous pressure (CVP) without causing significant changes in mean arterial pressure, whereas higher levels of LBNP decrease ar-terial pressure as well as CVP.2 '`Thus, the first type of stimulus induces a selective unloading of cardiopulmonary baroreceptors while the second inhibits both arterial and cardiopulmonary baroreceptors.2' 10 Furthermore, to assess the specific role of ventricular sensory receptors we also compared the hemodynamic responses evoked by LBNP before and after the intravenous administration of propranolol.
Methods
Patients. The study was performed in 14 patients (eight men; six women; mean age 34 + 3 years) with mild or moderate essential hypertension. In all blood pressure readings were above 160 mm Hg systolic and 95 mm Hg diastolic on at least five consecutive readings in the outpatient clinic in the absence of any antihypertensive treatment. None of the patients had received drugs for at least 3 weeks before the study. Blood pressure was measured with the subject in the sitting position, after a 10 min rest in a darkened room, by means of a standard sphygmomanometer with a cuff of appropriate size, and following the recommendations of the American Heart Association. 1 ' Secondary hypertension was ruled out in all patients by laboratory and x-ray studies. The control group consisted of 14 ageand sex-matched normotensive subjects (eight men and six women; mean age 33 + 3 years). In the study population the presence of major diseases, other than hypertension in the hypertensive patients, was ruled out. All the patients were fully informed about the procedures and aims of the study, and written consent was obtained in all cases before the study. The experimental protocol was approved by the Ethical Committee of our institution. None of the normotensive subjects had LVH, as assessed by electrocardiographic12 and echocardiographic'3 examinations before the study. All the hypertensive patients satisfied the electrocardiographic and echocardiographic criteria for LVH.
In the week preceding the study session the patients were hospitalized. During this period, they received a daily diet containing 1500 ml of fluids, 150 meq of sodium, and 70 meq of potassium. From day 4 to day 7, it was verified on the basis of body weight, sodium intake, and urinary sodium output that sodium balance was maintained at a steady state. In hypertensive patients, at the fourth day of hospitalization the systolic and/or the diastolic pressure, measured at bed side with a mercury sphygmomanometer, was constantly above the accepted limits of normal blood pressure, i.e., 90 nim Hg diastolic and 160 mm Hg systolic. All patients underwent two-dimensional and M mode echocardiography, which was performed as previously reported from this laboratory.'4 Two days before the study session the subjects were made familiar with the device for applying LBNP and the neck chamber.
Procedures. The primary study was carried out in seven hypertensive patients (four men and three women, mean age 34 + 4 years) and seven control subjects (four men and three women) of the same age (33 + 4 years) and body surface area (hypertensive patients: 1.79 + 07 m2, control subjects: 1.84 + 05 mi2, NS). Forearm volume was measured by water displacement. The subjects were then placed in the recumbent position, in a control environment with a temperature of 20 + 10 C, with the right arm relaxed and supported at the midthoracic level.
The internal diameter of the brachial artery was determined by means of transcutaneous pulsed Doppler velocimetry (Echovar Doppler Pulsed, Alvar Electronic, Montreuil, France). The Doppler velocimeter operated at a frequency of 8 MHz and pulsed at 15 kHz and was equipped with two original features as described by Safar et al. 5 The probe position was adjusted over the brachial artery and fixed throughout the study by means of a stereotaxic device placed around the arm.15 Flow through the brachial artery was measured according to the technique of Safar et al. 5', 16 The random variability between repeated measurements with this method was 7 + 2% and results with this technique have been reported to correlate with measurements in vitro. 17 In humans, arterial flow to superficial arteries deduced from concomitant pulsed Doppler measurements of diameter and blood velocity have been found to be strongly correlated with the brachial artery-to-forearm arterial flow measured by strain-gauge plethysmography. 16 Blood pressure was measured in the left arm by sphygmomanometry, with one observer obtaining all measurements. Heart rate and rhythm were monitored continuously by electrocardiography. Forearm vascular resistance (expressed in mm Hg/ml/sec) was calculated by dividing mean arterial pressure (diastolic pressure + 1/3 of pulse pressure in mm Hg) by brachial arterial blood flow.
LBNP was applied with a chamber placed around the subject's body below the iliac crest. The chamber was sealed and connected to an adjustable vacuum, according to the technique described by Mark et al. 6 Measurements of forearm blood flow and blood pressure were recorded before and during 2 min of LBNP. Responses to LBNP at -10 and -40 mm Hg were determined. A transcutaneous venous catheter was inserted through a vein of the arm and positioned under fluoroscopic control in the right atrium for measurements of CVP.
The specificity of the effect of propranolol on cardiac baroreflexes was assessed by also evaluating the effects of this drug on the vasoconstrictor response to the somatic pressor reflex (sustained handgrip) and cold pressor test. The somatic pressor response was evaluated through the technique of sustained (2 min) left handgrip using an exercise dynamometer at 75% of the subject's maximal voluntary contraction. Response to the cold pressor test was evaluated by immersion of the subject's left hand in ice water for 90 sec. An ancillary study was performed in seven hypertensive patients (four men and three women, mean age 33 + 4 years) and seven control subjects (four men and three women, mean age 34 + 2 years). They were 14 nonconsecutive patients with normal coronary arteriograms who underwent coronary arteriography to define the cause of their chest pain syndrome. None of them had electrocardiographic evidence of myocardial infarction or an exercise stress test positive for ischemic heart disease. Under local anesthesia with 2% lidocaine, a heparinized arterial catheter was introduced percutaneously into the right brachial artery and positioned under fluoroscopy in the ascending aorta for direct measurement of systemic blood pressure. Mean arterial pressure was obtained by the integration of the pulsatile trace over periods of 5 sec. A No. 7 triple-lumen thermodilution Swan-Ganz catheter was introduced percutaneously into an antecubital vein and positioned in the pulmonary artery and cardiac output was assessed in triplicate with a 9520-A Edwards cardiac output computer. Right atrial, pulmonary arterial, and pulmonary capillary wedge pressures were also recorded. An electrocardiographic lead was monitored during the study, and the patients were asked to breathe regularly. Systemic and pulmonary arterial pressure were continuously measured with a Statham P23Db pressure transducer and recorded simultaneously with the electrocardiogram on a OTE BIOMEDICA EP12 Multichannel Polygraph. All tracings were simultaneously recorded at a paper speed of 100 mm/sec. A polyethylene catheter was introduced into an antecubital vein for drug administration.
Baseline hemodynamics recorded included arterial pressure, right heart pressures, and cardiac output. Systemic vascular resistance (dyne.sec.cm-5) was calculated as (mean arterial pressureright atrial pressure)/(cardiac output).80. LBNP Vol. 74, No. 5, November 1986 981 was performed as described above. Arterial baroreceptor responsiveness was also evaluated. It was assessed by the slope of the relationship obtained by plotting systolic blood pressure against the RR interval after the intravenous injection of phenylephrine (2 gug/kg). 8 Also, carotid baroreceptors were unloaded by increased neck pressure by means of a neck chamber, as previously described. 18 Neck pressure was applied at + 60 mm Hg for 2 min to decrease transmural carotid pressure and thereby unload the carotid baroreceptors. The hemodynamic effects induced by changes in neck tissue pressure were analyzed according to Mancia et al. 19 by dividing arterial pressure and heart interval values into (1) a control value (the average value during 30 sec preceding the change in neck tissue pressure), (2) the early response (the average value in the 10 sec period from the fifth to the fifteenth second after the change in neck tissue pressure), and (3) the steady-state response (the average value during the last 30 sec of the change in neck tissue pressure). Protocol. The study was performed in a quiet room with the temperature between 24 and 260 C on day 7 of hospitalization after the patients had fasted ovemight. No premedication was administered.
Primary study. After baseline measurements of brachial blood flow, heart rate, and blood pressure, the responses to LBNP of -10 and -40 mm Hg, sustained handgrip, and the cold pressor test were recorded. Interventions were performed in random order. The subjects were then given 0.1 mg/kg iv propranolol over 10 min. After a 20 min rest period measurements of baseline hemodynamics and response to the reflex stimuli were repeated.
In five hypertensive and five normotensive subjects, all the responses were also recorded before and 30 min after the intravenous administration of vehicle.
Ancillary study. Systemic, heart, and pulmonary pressures were determined continuously over 90 sec at baseline and then during sequential LBNP at -10 and -40 mm Hg for 120 sec each. Cardiac output was determined before and at the end of each intervention period. The hemodynamic response to intravenous phenylephrine and a 60 mm Hg increase in neck tissue pressure was also assessed. Propranolol, 0.1 mg/kg iv, was then given over 10 min. After a 20 min rest period measurements of the responses to all the stimuli were repeated. In six patients, three hypertensive and three control, we determined the reflex responses 20 min after the administration of the vehicle.
Statistical analysis. Baseline values before and after pro-pranolol and responses to handgrip, the cold pressor test, and baroreceptor unloading by neck chamber or loading by phenylephrine injection were compared by the paired t test. The comparison between the corresponding values in two groups and the responses to the two levels of LBNP before and after propranolol was performed by analysis of variance. Comparison of regression lines was performed according to standard methods.20
Results
Primary study Resting measurements. Systolic and diastolic arterial pressure and forearm vascular resistance were significantly higher in hypertensive patients than in normotensive subjects (tables 1 and 2). Although CVP tended to be higher in hypertensive patients, the difference was not significant (7.3 0.9 vs 5.9 + 0.4 mm Hg).
The two groups were also different with respect to the echocardiographic measurements of left ventricular posterior wall and interventricular septal thickness and left ventricular mass index (table 1). No significant difference was detected between the two groups for left ventricular dimensions (normotensive subjects: diastolic = 5.2 + 0.1 cm, systolic = 3.5 + 0.1 cm; hypertensive patients: diastolic = 5.3 ± 0.2 cm, systolic =3.7 ± 0.2 cm).
Responses to LBNP. In both groups -10 and -40 mm Hg LBNP decreased CVP and forearm blood flow and increased forearm vascular resistance (table 2) . Mean arterial pressure and heart rate did not change significantly at -10 mm Hg LBNP. At -40 mm Hg mean arterial pressure remained unmodified while heart rate rose significantly in both groups of subjects (table 2) . Changes in CVP, blood flow, and forearm vascular resistance induced by the two levels of LBNP did not differ in normotensive and hypertensive subjects (table Values are mean ± SE; n = 7.
Blood pressure and heart rate were obtained in patients in the supine resting state immediately before the echocardiographic study. SAP = systolic arterial pressure; DAP = diastolic arterial pressure; HR = heart rate; IVST = interventricular septal thickness; PWTposterior wall thickness; LVMi = left ventricular mass index.
Ap < .01 normotensive vs hypertensive in each study. Values are mean ± SE; n = 7. SAP = systolic arterial pressure; DAP = diastolic arterial pressure; MAP = pressure; FBF = forearm blood flow; FVR = forearm vascular resistance. mean arterial pressure; HR = heart rate; CVP = central venous Ap < .01 baseline vs -10 or -40 mm Hg LBNP; Bp < .01 control vs propranolol; cp < .01 normotensive vs hypertensive.
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2). Consequently, no statistically significant difference was detectable between the slopes of the regression lines obtained in the two groups by plotting the changes in CVP induced by -10 and -40 mm Hg LBNP against the corresponding increases in forearm vascular resistance (figure 1). Intravenous administration of propranolol (0.1 mg/kg body weight) decreased heart rate and increased forearm vascular resistance in both groups (table 2) .
After administration of propranolol, CVP showed graded falls at the two levels of LBNP and these were comparable in magnitude to those observed under control conditions (table 2). In hypertensive patients, propranolol also failed to modify the reflex response to LBNP (change in forearm vascular resistance [mm Hg/ml/sec] at -10 mm Hg -+ 77 ± 15 before and + 105 ± 22 after propranolol, NS; at -40 mm Hg = + 188 ± 28 before and + 227 ± 31 after propranolol, NS). In contrast, in normotensive subjects there was a smaller increase in forearm vascular resistance at -40 mm Hg after propranolol (at-10 mm Hg + 76 ± 12 before and +56 ± 9 after propranolol, NS; at -40 mm Hg + 129 + 15 before and + 107 ± 5 after propranolol, p < .05). The relationship between the Vol. 74, No. 5, November 1986 decreases in CVP induced by the two levels of LBNP and the simultaneous increases in forearm vascular resistance remained significant after propranolol in both groups (figure 1). However, the slope of the regression line obtained from normotensive subjects after propranolol was significantly smaller compared with that obtained from hypertensive patients both before and after propranolol (all p < .01) (figure 1).
Response to handgrip and the cold pressor test. Table 3 summarizes the responses to activation of the somatic pressor reflex by sustained handgrip and responses to the cold pressor test. The forearm vasoconstrictor responses to handgrip and the cold pressor test were unchanged after propranolol. These responses contrast with the attenuation of the vasoconstrictor responses to LBNP in normal subjects.
Ancillary study. The clinical characteristics of those in the two ancillary study groups are summarized in table 1. No significant difference could be detected in the considered variables between these patients and those who participated in the primary study. The baseline hemodynamics before and after propranolol in this study population are summarized in Values are mean + SE; n = 7. SAP = systolic arterial pressure; DAP = diastolic arterial pressure; MAP = mean arterial pressure; HR = heart rate; CVP = central venous pressure; PCWP = pulmonary capillary wedge pressure; CO = cardiac output; TPR = total peripheral resistance.
A and Bp < .05 and p < .01, respectively, baseline vs -10 and -40 mm Hg LBNP; cp < .01, normotensive vs hypertensive; D and Ep < .05 and p < .01, respectively, before vs after propranolol.
higher mean blood pressure and total peripheral resistance compared with normotensive control subjects (table 4). The intravenous administration of propranolol significantly reduced heart rate and cardiac output and increased total peripheral resistance (table 4) .
LBNP at -10 and -40 mm Hg induced a graded reduction in CVP that was of a similar extent in the two groups (table 4) . This phenomenon was accompanied by a reduction in cardiac output and an increase in total peripheral resistance without any change in mean blood pressure (table 4) . Heart rate rose significantly in the two groups only at -40 mm Hg LBNP (table 4) . Pulmonary capillary wedge pressure fell to a comparable extent in the two groups at both levels of LBNP (table 4 ). The fall in CVP and that in pulmonary capillary wedge pressure were significantly correlated with the increases in total peripheral resistance induced by LBNP (figure 2). No significant difference between the slopes of the corresponding correlations for the two Vol. 74, No. 5, November 1986 groups could be detected. After treatment with propranolol, the two levels of LBNP induced changes in CVP as well as in pulmonary capillary wedge pressure that were comparable to those recorded in the basal state (table 4). In normotensive subjects a significant reduction in the response of total peripheral resistance to -40 mm Hg LBNP was detected (control conditions +202 ± 37 dyne-sec-cm-5, after propranolol + 136 + 31 dyne.sec.cm-5, p < .05). In hypertensive patients, no change in the response of total peripheral resistance to either level of LBNP could be detected after propranolol (at -10 mm Hg LBNP = + 106 + 36 dyne-sec-cm`before and + 152 ± 50 dyne-*sec,cm after propranolol; at-40 mm Hg LBNP = + 328 ± 65 dyne sec cm-5 before and + 372 ± 44 dyne.sec.cm-5 after propranolol). Therefore, after propranolol the slopes of the correlations between the increases in total peripheral resistance and the decreases in CVP or pulmonary capillary wedge pressure . Finally, no significant change in arterial baroreceptor response to selective unloading of the carotid baroreceptors by neck chamber or to generalized baroreceptor stimulation by phenylephrine injection was observed in either group after propranolol (table 5). The significant reduction in arterial baroreceptor responsiveness observed in hypertensive patients as compared with that in normotensive subjects under control conditions remained unchanged after propranolol.
Discussion
Our results seem to support two main conclusions: (1) There is no substantial difference between the hemodynamic response elicited by the unloading of the cardiopulmonary receptors in patients with established hypertension and LVH and the response of normotensive control subjects. (2) LVH induced by hypertension is associated with changes in the role of the different receptor areas participating in the mediation of the systemic hemodynamic response to simulated orthostatic stress. This latter phenomenon seems to be 986 -.9327, p < .001).
due to an impairment of the left ventricular sensory receptors.
In our hypertensive patients with LVH, the reflex vascular responses to both levels of LBNP, despite a slight tendency to be higher, could not be differentiated from those observed in normotensive subjects. In particular, in the noninvasive study we assessed the reflex vascular response to cardiopulmonary receptor unloading in the forearm vascular bed since forearm vascular tone has been shown to be strongly influenced in humans by receptors located on the "low pressure" system.2' 22 To investigate the forearm vascular response we used pulsed Doppler flowmetry. The advantages of this technique in comparison with water or strain-gauge plethysmography in measuring brief vasomotor responses are well known.23 However, the close relationship reported between the results obtained by plethysmography and those obtained by Doppler flowmetry23 is confirmed by the fact that, using the Doppler technique, we demonstrated in normotensive subjects a forearm vascular response to LBNP quite comparable to that described by previous authors using plethysmographic methods.8 According to Mark and reduction in the tonic inhibitory influence of cardiopulmonary receptors with vagal afferents on the vasomotor centers.2' 10 Cardiopulmonary receptors with nonmedullated vagal afferents include reflexogenic areas in atria, ventricles, and lungs that are sensitive to changes in cardiac filling pressures.24 Thus, LBNP would be expected to decrease the inhibitory input from these receptors and result in increased sympathet-ic activity.25 A question arises as to the type and location of the cardiopulmonary receptors that mediate the forearm vascular response to LBNP in man. Animal studies demonstrate that afferent vagal nerves from lungs and the heart tonically inhibit the vasomotor center and that the inhibition exerted by the heart is caused by receptors in the atria and the ventricles. 26 More recently, Ferguson et al. 8 have suggested In particular, Thoren9 observed in the cat that propranolol decreases ventricular contractility and produces a marked reduction in the sensitivity of left ventricular receptors with nonmyelinated vagal afferents. Subsequently, Thames27 has shown that the i-isomer of propranolol produces a marked decrease in the sensitivity of ventricular C fibers, but does not decrease the sensitivity of atrial mechanoreceptors with C fiber vagal afferents. This differential effect was thought to result from the large influence of the inotropic state on the activity of the ventricular, but not atrial, C fibers.27 To the extent that these results can be extrapolated to human beings, the reduction of the slope of the relationship between the LBNP-induced decrease in CVP and the increase in forearm vascular resistance observed after propranolol in normotensive subjects seems to confirm the data of Ferguson et al. 8 However, when considered separately, the response to -40 mm Hg LBNP, but not that to -10 mm Hg LBNP, was significantly reduced after propranolol. Since this level of LBNP induces a simultaneous inhibition of cardiopulmonary and arterial baroreceptors, one could speculate that the response of arterial baroreceptors more than that of ventricular sensory receptor is attenuated by propranolol. The results obtained in the invasive study, which demonstrate that propranolol does not modify the reflex response to phenylephrine or to an increase in neck tissue pressure, seem to rule out this hypothesis and to confirm the reports of previous authors8 28 that propranolol does not reduce the discharge of aortic and carotid baroreceptors. Similarly, the observation that propranolol does not attenuate the reflex response to stimuli other than LBNP makes unlikely the possibility that a central nervous system effect of propranolol could account for its effect on the response to LBNP. Finally, since in our study propranolol induced a significant increase in baseline vascular resistance, which was more marked in normotensive than in hypertensive subjects, it may be hypothesized that this phenomenon might impair the response to any type of vasoconstrictive stimuli. This hypothesis is also ruled out by the demonstration that after propranolol the increase in vascular resistance induced by handgrip and the cold pressor test is unchanged or even increased. Therefore, our results seem to lend further support to the conclusions of Ferguson et al.8 that the blunted vasoconstric-988 tive response to LBNP observed after propranolol in normotensive subjects is to be ascribed to the effects of this drug on left ventricular receptors. As a consequence, the lack of change after propranolol in the forearm vasoconstrictor response to LBNP in hypertensive patients with LVH should indicate that in these patients the propranolol-sensitive left ventricular receptors have lost their role in the mediation of this reflex response and that other baroreceptor areas in the cardiopulmonary vascular bed compensate for the impairment of these receptors.
Alternatively, the unchanged forearm vascular response to -40 mm Hg LBNP observed after propranolol in hypertensive patients may be accounted for by blunted cardiac sympathetic nerve activity, or by changes in the state of left ventricular sensory receptors induced by propranolol through factors independent of sympathetic influence. With regard to the first possibility, it has been reported that propranolol reduces the discharge of cardiac vagal C fibers through a decrease in contractility caused by /3-adrenergicreceptor blockade.27 Thus, it may be speculated that the effect of propranolol on ventricular sensory receptors may be depressed in the presence of a reduced sympathetic drive to the heart. Although the possibility that such a mechanism could have affected our data cannot be completely ruled out, the observation that the decrease in heart rate induced by propranolol in our hypertensive patients was comparable to that observed in normotensive subjects makes it unlikely that our hypertensive patients had lower levels of cardiac sympathetic nerve activity than the normotensive control subjects. The observation made by Thoren et al.24 that left ventricular sensory receptor activity is strongly correlated with left ventricular filling pressure suggests an alternative explanation for our findings, i.e., that factors independent of the cardiac sympathetic tone may account for the unchanged vascular response to -40 mm Hg LBNP after propranolol in hypertensive patients. In fact, the propranolol-induced increase in vascular resistance could have modified cardiac filling pressure and thus left ventricular sensory receptor activity to a different extent in the two groups. However, the finding that the changes in cardiac filling pressure induced by propranolol in our hypertensive patients were comparable to those observed in normal subjects seems to exclude such a possibility.
What are the mechanisms underlying the impairment of left ventricular sensory receptors in hypertensive patients? We considered two possibilities: (1) that LBNP does not produce an adequate stimulus for unloading of ventricular sensory receptors in these pa-CIRCULATION PATHOPHYSIOLOGY AND NATURAL HISTORY-HYPERTENSION tients, and (2) that a decrease in the sensitivity of the ventricular sensory receptors may mediate the impaired reflex response to LBNP in hypertensive patients with LVH. To distinguish between these two possibilities, we performed the invasive study, which was designed to compare the effects of LBNP on cardiac filling pressure in normotensive and in hypertensive patients. To simplify the procedures of this study we chose to evaluate the reflex response to LBNP by measuring the changes in total peripheral resistance induced by this stimulus. This decision may appear to disregard the data of Oberg and Thoren,29 who reported that cardiopulmonary receptors subserved by vagal afferents exert a tonic inhibitory influence on the vasomotor neurons controlling the efferent sympathetic discharge to muscle and renal resistance vessels. However, Mancia and Donald26 have demonstrated, in dogs on constant-flow extracorporeal circulation in which changes in aortic pressure reflect changes in total peripheral resistance, that the inhibition of the cardiopulmonary receptors can induce changes in arterial pressure. In keeping with this observation is the correspondence of the results obtained in the invasive study with those obtained by evaluating the effects of LBNP on the forearm vascular resistance. The finding that in hypertensive patients LBNP induces changes in cardiac filling pressure comparable in magnitude to those observed in normal subjects, while minimizing the possibility that the increase in ventricular wall thickness may reduce the changes in left ventricular filling pressure, seems to support the hypothesis that LVH impairs the sensitivity of left ventricular sensory receptors.
In an attempt to explain the finding that under control conditions hypertensive patients with LVH show hemodynamic responses to LBNP similar to those observed in normotensive subjects, it could be postulated that arterial baroreceptors or cardiopulmonary receptors other than left ventricular sensory receptors play a major role in the reflex control of vascular resistance in hypertensive patients. The possibility that arterial baroreceptors may compensate for impaired left ventricular sensory receptor function is supported by the report of Thames and Johnson.30 These authors have recently shown that in renal hypertensive rabbits arterial baroreflexes, albeit abnormal ones, partially compensate for the markedly impaired cardiopulmonary baroreflex control of the renal nerves. On the other hand, Mancia and Donald26 have demonstrated that vagal block causes comparable increases in blood pressure in dogs from which the lungs have been removed and only the atria or ventricles are innervated. In addition, these authors found that whatever cardiac chamber was denervated, the increase in blood pressure evoked by vagal block was comparable to that observed in animals whose hearts were untouched. On the basis of these latter experiments and our present data, it could also be speculated that the progressive impairment of the function of ventricular sensory receptors that occurs in hypertensive patients with LVH is compensated for by atrial or other cardiopulmonary receptor areas, thus maintaining the net response to simulated orthostatic stress.
